The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Clinical trial NCT07038304 · RECRUITING

Trial details

NCT number: NCT07038304
Sponsor: University Medical Center Groningen
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic Disease Castration Resistant Metastatic Prostate Cancer Radiotherapy

Start date: 2025-01-03
Primary completion: 2028-01-03
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.